Health ❯ Medicine ❯ Pharmaceuticals

Drug Development

Obesity Treatments Clinical Trials Alzheimer's Disease Weight Loss Drugs Inflammatory Bowel Disease Weight Loss Treatments Pain Medication Muscle-Activating Compounds ERR Protein Activation Semaglutide Research and Development Amylyx Pharmaceuticals Drug Withdrawal Regulatory Updates Regulatory Approval Chemotherapeutic Drugs Gepotidacin Donidalorsen Sildenafil Gleevec Synthesis Methods Malaria Treatment Sarepta Therapeutics COPD Treatment Quantum Computing in Medicine Leucovorin Synthetic Proteins Oncology Weight Loss Medications Synthetic Biology Existing Drugs FDA Approval Cancer Treatments

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

Regulators limited the relaunch to one regimen because safety concerns offset strong efficacy data.